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Progressive adriamycin nephropathy in mice: Sequence of his- the administration of aminonucleoside [1, 2], protein
tologic and immunohistochemical events. overload [3, 4], partial nephrectomy [5, 6], and the ad-
Background. As an experimental analogue of human focal ministration of adriamycin (ADR) [7–9], have been de-glomerular sclerosis (FGS), adriamycin (ADR)-induced ne-
scribed in rats. Among these, the ADR-induced ne-phropathy is well-characterized in rats. Previously, this model
phropathy model is considered to be an experimentalhas not been fully established in mice. The extension of this
model to the mouse would be useful in the application of analogue of human minimal lesion nephrotic syndrome
genetic and monoclonal antibody technology to characterize and FGS [7, 9]. Furthermore, a long-term study of this
mechanisms of progressive renal disease. Herein, we describe
model in rats demonstrated severe renal damage witha stable and reproducible murine model of chronic proteinuria
features characteristic of chronic progressive renal dis-induced by ADR.
Methods. Male BALB/c mice were intravenously injected ease in humans [9, 10]. Although ADR-induced chronic
with a single dose of ADR (10 to 11 mg/kg). Seven mice were nephropathy has been well characterized in rats for some
sacrificed at weeks 1, 2, 4, and 6. Renal function, quantitative time, this model has not been fully established in the
morphometric analysis, and electron microscopic studies were
mouse [11, 12]. A recent report from Chen et al describedperformed. Peripheral CD41 and CD81 T cells were evaluated
experimental FGS in BALB/c mice induced by ADR,using flow cytometric analysis of splenocytes. The leukocytic
inflammatory pattern was analyzed by immunohistochemical with an observation period extended only to 18 days
examination. [13].
Results. Overt proteinuria was observed from day 5 and The present study was designed to establish and char-
remained significantly elevated throughout the study period.
acterize a stable and reproducible murine model ofA focal increase in reabsorption droplets in tubular cells ap-
chronic progressive nephropathy with significant andpeared at weeks 1 and 2, and numerous intraluminal casts were
present after two weeks. Glomerular vacuolation and mild FGS persistent proteinuria using ADR. Such a murine model
appeared at week 4. At week 6, extensive focal and even global carries the special advantages of economy and the poten-
glomerular sclerosis, associated with moderate interstitial tial for application of genetic and monoclonal antibodyexpansion and severe inflammation, were observed. A promi-
manipulation to study pathogenesis.nent macrophage infiltration appeared within both interstitium
and glomeruli at week 2, followed by accumulation of both
CD41 and CD81 T cells in interstitium but not glomeruli.
METHODSThere were almost no B lymphocytes seen at any time.
Conclusion. This model should be useful in unraveling the Male BALB/c mice weighing 20 to 25 g and aged eight
pathogenesis of glomerular and interstitial inflammation and weeks were obtained from the Animal Care Facility,fibrosis in chronic proteinuric renal disease.
Westmead Hospital (NSW, Australia). Dose-finding
studies defined an optimal dose of 10 to 11 mg/kg body
wt of ADR (Doxorubicin Hydrochloride; Pharmacia &Experimental focal glomerular sclerosis (FGS) can be
Upjohn Pty Ltd., Perth, Australia). ADR was injectedinduced by both immunologic and nonimmunological
once via the tail vein of each nonanesthetized mouse.methods. Most nonimmunological procedures, such as
Seven age-matched male BALB/c mice were injected
with same volume of isotonic saline. All control and
experimental mice were housed individually, and onceKey words: glomerulosclerosis, proteinuria, tubulointerstitial fibrosis,
inflammation. a week, a 12-hour collection of spontaneously voided
urine was made from each animal. Body weight, urineReceived for publication November 22, 1999
volume, and urinary protein were measured weekly.and in revised form March 7, 2000
Accepted for publication April 25, 2000 Seven mice treated with ADR were sacrificed at weeks
1, 2, 4, and 6. Blood samples for serum albumin andÓ 2000 by the International Society of Nephrology
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Table 1. Monoclonal antibodies (mAbs) used in FACS and immunohistochemical staining
Clone Target molecule Specificity Reference
RM4–5 Murine L3T4 MHC class II-restricted T lymphocytes, including [15]
most T helper cells
53–6.7 Murine Ly-2 MHC class I-restricted T lymphocytes, including most [16]
T suppressor/cytotoxic cells
M3/84 Murine Mac-3 Tissue macrophages, some myeloid cell lines, but not [17]
lymphocytes or monocytes
RA3-6B2 Murine CD45R/B220 Pan-B lymphocytes marker, at all stages from pro-B [18]
through mature and activated B cells
All antibodies were purchased from Pharmingen Company (Becton Dickinson and Company, New Jersey, USA). FACS is fluorescence-activated cell sorter.
creatinine were obtained by cardiac puncture under an- staining procedures used were modified slightly from
those previously reported [19]. Briefly, spleen cell sus-esthetic (ketamine/xylazine, 100/8 mg/kg body weight),
pensions were made in RPMI 1640 medium (GIBCOand then animals were completely exsanguinated via the
BRL Life Technologies Inc., Grand Island, NY, USA)abdominal aorta to minimize the number of circulating
with 10% (vol/vol) fetal calf serum (FCS; Trace Biosci-inflammatory cells remaining in harvested kidney and
ences Pty Ltd., Castle Hill, NSW, Australia) and thenspleen. Kidney weight and body weight were measured
separated by centrifugation in 48C. Red blood cells wereimmediately. All kidney and spleen specimens were pro-
lyzed, and the number of viable cells was determined.cessed without delay.
Three 3 105 cells in 100 mL of medium were incubatedPlasma and urinary creatinine were analyzed using a
with 10 mL of the relevant antibodies at room tempera-BM/Hitachi 747 analyzer (Tokyo, Japan). Total urinary
ture for 10 minutes in the dark. Washing twice usingprotein was quantitatively determined using the Bio-
phosphate-buffered saline (PBS) with 5% FCS, cellsRad protein assay (Bio-Rad Laboratories, Hercules, CA,
were fixed with 2% (wt/vol) paraformaldehyde andUSA) according to the manufacturer’s instructions in a
stored in the dark at 48C until the cells were analyzedDU-68 Spectrophotometer (Beckman Instrument, Inc.,
using a FACScan (Becton Dickinson). The immunohis-Irvine, CA, USA), for which purified bovine serum albu-
tochemical (IHC) staining was performed by the follow-
min (BSA; Sigma Chemical Company, St. Louis, MO, ing protocol: 5 m cryostat sections of both kidney and
USA) at concentration ranges 0.2 to 1.5 mg/mL was spleen were placed on slides previously coated with
used as a reference standard. Urine samples were also 0.01% (wt/vol) of poly-l-lysine (Sigma). Sections were
examined for hematuria and leukocyturia using the Re- fixed in Zamboni’s fixative [20] for 30 minutes at 48C
agent Strips for Urinalysis (Bayer Australia Ltd., Pymble and then passed through methanol for five minutes and
NSW, Australia). acetone for one minute at 2208C. An avidin-biotin com-
A piece of renal tissue was placed in 10% neutral- plex (ABC) technique was used. The primary mAbs are
buffered formalin fixative at room temperature for 12 also listed in Table 1. The secondary antibody was a
hours, embedded in paraffin, evaluated using 4 m sec- biotinylated rabbit anti-rat immunoglobulin (Dako Cor-
tions, and stained with periodic acid-Schiff (PAS), hema- poration, Carpinteria, CA, USA). For negative controls,
toxylin and eosin (HE), and Masson’s trichrome. Quanti- primary antibodies were replaced with equivalent con-
tative evaluation of FGS, tubular and interstitial lesions centrations of normal rat immunoglobulin. All speci-
mens were stained in duplicate. To avoid false negativewas performed using an image analysis system (Optimas
staining, a spleen section was placed and stained on every5.23; Optimas Corporation, Seattle, WA, USA) as de-
slide as a positive control. Brown staining of cells wasscribed previously [14]. Mean values were calculated
regarded as positive immunoreactivity. The number offrom each of 20 glomeruli or tubules or 10 random corti-
positive cells was evaluated from the mean of five corticalcal regions per section.
and medullary fields (magnification 3400) in each sec-For electron microscopy, kidney specimens were fixed
tion.in modified Karnovsky’s fixative buffer for two hours,
Two-way analysis of variance was used in all statisticalwashed two times in 0.1 mol/L MOPS buffer, and then
tests. Bonferroni’s correction was used for multiple com-postfixed in 2% buffered osmium tetroxide. After dehy-
parison. Results are represented as mean 6 SD. A valuedration in a graded ethanol series, specimens were em-
of P less than 0.05 was considered to indicate statisticalbedded in epoxy resin. Ultrathin sections were stained
significance.with uranyl acetate and lead citrate and examined in a
Philips CM201s electron microscope.
RESULTSThe sources and specificities of monoclonal antibodies
(mAbs) used for fluorescence-activated cell sorter In a series of preliminary experiments, we attempted
to induce nephropathy in two different strains of mice:(FACS) analysis are listed in Table 1 [15–18]. The FACS
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Fig. 1. Mean body weight (A), total urinary protein (B), ratio of kidney weight/body weight (C ), serum albumin (D), creatinine clearance (E),
relative interstitial volume (F ), mean percentage of glomerulosclerosis (G), and mean number of nuclei per glomerulus (H ) for groups with saline-
treated (r) and adriamycin (ADR)-treated (j) mice plotted against time. Values are expressed as means 6 SD. *P , 0.05; **P , 0.01.
BALB/c and C57BL/6J. C57BL/6J mice either failed to with wide individual variations. A high dosage of ADR
(more than 12 mg/kg body weight) by single injectiondevelop any significant proteinuria or histologic change,
even at eight weeks after ADR injection of 15 mg/kg caused dehydration, gastrointestinal bleeding, or severe
hematuria and, in about 25% of experimental mice, se-body weight or died within two weeks of ADR injection
of 20 mg/kg body weight or more. In contrast, in BALB/c vere cachexia, causing death before week 3. A similar
phenomenon has also been described by Chen et al [13].mice, a single injection of ADR less than 10 mg/kg body
weight or a double injection with a total dosage of up However, in the present study, using an average dosage
of 10.5 mg/kg body weight in a 2 mg/mL solution (rangeto 14 mg/kg body weight produced an unstable model
Fig. 5. Typical immunostaining of kidney cor-
tex. The frozen sections from saline-treated
(a) and ADR-treated (b) kidneys at six weeks.
Stained with MAb 53-6.7 (discussed in the text).
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Fig. 2. (a) Saline-treated control mice showed morphologically normal glomeruli and tubules. (b) ADR-treated mice at week 2 showed glomerular
hypertrophy and hyaline deposits (arrow). Resorption droplets (arrowhead) in tubule cells, as well as intratubular casts, were also found. Some
tubules were normal. (c) At week 4, mesangial expansion (arrow) in glomeruli, tubular vacuolization (arrowhead), and mild interstitial proliferation
were found. Well-developed exudative (fibrin-cap) lesions were also easily seen in glomeruli. (d) Global glomerular sclerosis (arrow), tubular
collapse (arrowhead), and severe interstitial expansion were seen at week 6. Micrographs a–d were stained by PAS. ( f ) The number of nuclei
was reduced in glomeruli and accompanied by a significant interstitial infiltration at week 6, as compared with control (e). Both were stained by
HE (3400).
10 to 11 mg/kg body weight), all BALB/c male mice of tubular epithelial cells, a loss of brush border, and
vacuolization. The interstitial volume increased mildlytreated with ADR developed nephrotic syndrome and
remained alive throughout the study period of up to and focally, but there was a moderate interstitial mono-
cyte infiltration. Glomeruli were reduced in size witheight weeks.
several vacuoles, collapse of tuft, as well as expansion
General characteristics of the mesangium caused by an increase in PAS-positive
material. At week 6, tubular atrophy and intratubularAll experimental animals developed nephropathy
characterized by proteinuria, hypoalbuminemia, hyper- cast formation with tubulointerstitial expansion were
widely observed in the cortex. Extensive FGS and severecreatininemia, and progressive renal injury. As shown
in Figure 1A, the mean body weight of ADR groups fell interstitial fibrosis and inflammation were present. In
addition, global sclerosis was observed in many glo-quickly after treatment and reached its nadir at week 2,
after which body weight increased gradually and more meruli.
slowly than control. The surface of all kidneys of ADR-
Electron microscopic studytreated animals was granular and pale in color in compar-
ison to control. The kidneys were hypertrophied during Ultrastructural examination showed fusion of foot
processes of the glomerular epithelial cells in ADR-early nephrosis and atrophied later (Fig. 1C). Overt pro-
teinuria appeared at day 5 and was maximal at day 7. treated mice. The fusion was segmental at week 1 (Fig.
3) and widespread at week 6 (data not shown). NormalAt all time points after one week, high levels of protein-
uria were observed in all experimental animals (Fig. 1B). control mice failed to show any epithelial cell abnor-
mality.As determined by the Reagent Strips for Urinalysis, 10
of 28 mice (35.7%) had hematuria (graded from 2 to
FACS and IHC analysis31, equivalent to 25 to 80 red blood cells/mL), whereas
15 mice (53.6%) had leukocyturia (graded from 2 to 31, Peripheral T lymphocytes in spleen were analyzed us-
ing a FACScan. The mean percentage of CD41 andequivalent to 70 to 125 leukocytes/mL). No control mice
had hematuria or leukocyturia at any time point during CD81 cells among total leukocytes in spleen was 37 and
21%, respectively (Fig. 4a), in agreement with the resultsthe study period. ADR treatment produced a marked
fall of serum albumin by a median of 39% after one of other researchers [21, 22]. There were no significant
changes in either CD41 or CD81 cell numbers at anyweek, after which levels rose gradually but remained
persistently lower than control at all times. Creatinine time point in experimental animals (Fig. 4 b, c). IHC
examination of the renal tissue was performed at weeksclearance continued to decline with time and was signifi-
cantly different in comparison with control after week 2, 4, and 6 after ADR injection. Lymphocytes were rarely
seen within interstitium and were never identified in4 (Fig. 1E).
glomeruli of control animals, whereas a small population
Morphometric and histopathologic studies of macrophages could be found. CD41, CD81 T cells,
and macrophages was significantly increased in the kid-The mean number of cells (Fig. 1H) and relative capil-
lary area in each glomerulus fell throughout the experi- neys of ADR mice. In the earlier stages, macrophage
accumulation in the interstitium was prominent, andmental period, coincident with a significant increase in
mesangial matrix area. The degree of interstitial volume infiltration in the glomeruli could be readily found. Inter-
stitial macrophages appeared to originate in a sheathmarkedly increased with time (Fig. 1F), indicating the
severity of tubular interstitial expansion. Analysis by surrounding many glomeruli. However, macrophage in-
filtration dramatically decreased in later stages, accom-light microscopy demonstrated the serial changes in ex-
perimental kidneys (Fig. 2). At weeks 1 and 2, there was panied by a gradual increase in the number of T lympho-
cytes and development of renal injury, including tubulara focal increase in resorption droplets in tubular cells
and intraluminal casts. Glomeruli were increased in size, atrophy and interstitial expansion. The number of infil-
trating T lymphocytes within the interstitium increasedwith marked hyaline deposits. At week 4, tubules dis-
played severe changes, including a decrease in height throughout the evolution of the experiment (Table 2).
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characterize the mechanisms of progressive renal dis-
ease, and the real advantage of cost savings in terms of
animal purchase and maintenance, and use of expensive
interventions such as mAbs.
In preliminary experiments, we showed that the mu-
rine ADR model could be established in BALB/c but
not C57BL/6 mice. The reason for this difference is un-
known. Using eight inbred murine strains, Kimura et al
reported that BALB/c mice were highly susceptible to
nephrosis induced by daunomycin, which has a quite
similar structure to ADR, while C57BL/6J was com-
pletely resistant to it [23]. They reported that the strain
specificity in susceptibility to nephrosis is genetically con-
trolled, involving at least three genes (or clusters of
genes). Our experiment showed that BALB/c is a suit-
able but strictly dose-dependent strain for establishing
a stable and reproducible ADR nephropathy model.
In the present studies, overt proteinuria appeared
shortly after an intravenous injection of ADR and re-
mained significantly elevated throughout the experimen-
tal period. Furthermore, renal pathological, ultrastruc-
tural, and functional changes progressed during a long
observation period. The renal injury varied with time,
and the histologic hallmarks resembled those seen in
chronic renal diseases in humans. Interstitial inflamma-
tory cell infiltration is an early event in the development
of this murine ADR nephropathy, and the infiltration
consists of macrophages and T lymphocytes. The demon-
stration of initial interstitial infiltration by macrophages
at week 2, followed by accumulation of both CD41 andFig. 3. Ultrastructure of glomerular epithelial cells showed segmental
fusion of foot processes (arrow) in ADR-treated mice at week 1 CD81 T cells and the disappearance of macrophage in-
(317,800). filtration by week 6 as well as a virtual absence of B
lymphocytes, is consistent with previous observations
in other FGS models [4, 24–29]. The ultimate roles of
macrophages and T cells in glomerular and tubulointer-Both CD41 and CD81 cells were greatly increased at
stitial injury are still unclear. Macrophages have beenweek 6 compared with at week 4 (P , 0.01), both in
shown to mediate acute glomerular injury and to becortex and medulla. In contrast, T cells were never identi-
involved in the stimulation of mesangial cell proliferationfied within the glomerulus at any stage of the experiment.
and induction of FGS in many experimental modelsFigure 5 shows the IHC staining of CD81 cells in kidney
[25–28]. Macrophage-derived products, for example in-cortex. CD81 cells appeared to migrate from blood ves-
terleukin-1, interleukin-6, tumor necrosis factor-a, plate-sels and infiltrated the tubulointerstitium (Fig. 4b). No
let-derived growth factor, and transforming growthCD81 cells were seen in glomeruli even though glomeruli
factor-b, have been associated with glomerular injurywere closely surrounded by CD81 cells. CD41 cells fol-
and stimulation of mesangial cell proliferation and ma-lowed a similar distribution (data not shown). In contrast
trix formation [29]. The immune-activated macrophagesto T cells and macrophages, few if any B cells were found
may also play an important role in the immunopathogen-at any time.
esis of interstitial fibrosis in glomerulonephritis via a
delayed type hypersensitivity mechanism [29]. T lympho-
DISCUSSION cytes also appear to be important in the progression of
Despite an abundance of literature describing chronic renal injury. Accumulation and activation of macro-
nephropathy in rats, no model of chronic glomerular phages can be directed by T cells. Tipping, Neale, and
and tubulointerstitial changes induced by ADR has been Holdsworth proposed that glomerular macrophage infil-
convincingly established in mice. Extension of this model tration is dependent on T cells [24]. In preliminary exper-
to the mouse has the potential benefits of application iments, we found that a few CD41 T cells appeared in
juxtamedullary glomeruli in first 24 hours and disap-of gene knockout and transgenic mouse technology to
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Fig. 4. (A) Flow cytometry analysis of peripheral CD41 and CD81 cells (in spleen) with FITC-conjugated monoclonal antibodies (mAbs). The
X axis shows fluorescence intensity and the Y axis shows the relative cell number. Age-matched saline controls are shown in the upper panels,
and ADR-treated animals at week 6 are shown in the lower panels. Column 1: Background staining with rat IgG 2a, k isotype standard; column 2:
mAb RM4-5 (anti-L3T4); column 3: MAb 53-6.7 (anti-Ly-2). Stained cells were analyzed using the FACS-II with a logarithmic amplifier. (B and
C) Percentage of peripheral CD41 and CD81 cells measured by FACS at weeks 0, 2, 4, and 6 after ADR treatment. Symbols are: (j) ADR-
treated and (h) saline-treated age-matched groups.
Table 2. Frequency of interstitial CD41 and CD81 cells mation and fibrosis in chronic proteinuric renal disease.
(cell number/4003 field) by immunostaining
At present, a project using mAbs for in vivo manipula-
CD41 CD81 tion of T cell subsets is underway to investigate the link-
Week(s) Cortex Medulla Cortex Medulla age between T-cell infiltration and progressive interstitial
fibrosis in murine ADR nephropathy.0 1.861.5 1.661.1 0.260.5 0.460.6
2 12.464.3a 12.862.6a 9.961.7a 12.363.3a
4 25.867.7a 35.064.9a 20.464.1a 37.666.0a ACKNOWLEDGMENTS
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